JPRN-UMIN000008281招募中未知
Dose-escalation study of infliximab or methotrexate based on the disease activity in patients with rheumatoid arthritis treated with infliximab - Study of dose-escalation therapy in IFX-treated RA
Department of Internal Medicien and Rheumatology, Juntendo University School of Medicine0 个研究点目标入组 30 人开始时间: 2012年6月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with remmission and low disease acitivuty. Patients contraindicated or unsuitable to IFX administration, such as active infection.
研究者
相似试验
已完成
3 期
Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422)Arthritis, PsoriaticNCT00367237Merck Sharp & Dohme LLC115
已完成
3 期
COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)Crohn's DiseaseNCT00132899University of Western Ontario, Canada128
已完成
4 期
Infliximab and Methotrexate in Ankylosing SpondylitisAnkylosing SpondylitisNCT00507403University Hospital, Tours30
已完成
4 期
Combination Methotrexate and InfliximabAnkylosing SpondylitisNCT00432432Chinese University of Hong Kong38
已完成
不适用
Evaluation of efficacy of high dose infliximab with azathiopurine add-on therapy for patients with Crohn's disease refractory to low dose infliximabs diseaseCrohn's diseaseJPRN-UMIN000006232Saitama Medical University40